CD274 and cancer: Overall, both PD-L1 activity scores and CD274 expression levels associate strongly positively with glycolysis and negatively with OXPHOS, consistent with the largely antagonistic trend established for glycolysis and OXPHOS programs in the context of cancer progression [42].